VR
Vertex Pharmaceuticals
VRTX · NASDAQ
$546.12 -0.62% (-$3.38)
1M +4.24%
Market Cap $138.6B
P/E Ratio 31.46x
Div. Yield -
ROE 23.31%
Bulios Fair Price
$504.01
7.7% downside
Trenutna cena
$546.12
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VRTX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
17 /100
Expensive P/FCF 36.51x
P/E 31.46x
P/B 6.85x
Growth
46 /100
Stable FCF growth 6.64%
EPS growth 6.12%
Book val. growth 10.29%
Profitability
100 /100
Strong Op. margin 38.59%
Gross margin 86.04%
FCF margin 30.07%
Quality
86 /100
Excellent ROA 16.06%
ROIC 17.33%
Asset turnover 0.46x
Debt
100 /100
Low Int. coverage 800.23x
Debt/Equity 0.10x
Net debt/EBITDA -0.77x
Stability
41 /100
Moderate EPS volatility 517.44%
Beta 0.32x
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VRTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Reshma Kewalramani
Employees
6,400
Headquarters
Boston
Prihajajoči dogodki
02 NOV.
Earnings
Upcoming earnings report